Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid β peptide

Journal of Molecular Neuroscience

Volumn 22, Issue 1-2, 2004, Pages 13-18

  Pawlik, Monika ^a,b   Sastre, Magdalena ^a,d   Calero, Miguel ^c   Mathews, Paul M ^a,b   Schmidt, Stephen D ^b   Nixon, Ralph A ^a,b   Levy, Efrat ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

amyloid precursor protein; Alzheimer's disease; Amyloid ; Cystatin C; Protease inhibitor

Indexed keywords

AMYLOID BETA PROTEIN; CYSTATIN C; AMYLOID PRECURSOR PROTEIN; CYSTATIN; CYSTEINE PROTEINASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN BLOOD VESSEL; BRAIN LEVEL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN VARIANT; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN BINDING; SENILE PLAQUE; UPREGULATION;

MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CYSTATINS; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PROTEIN BINDING; SENILE PLAQUES; UP-REGULATION;

EID: 3042820505     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:1-2:13     Document Type: Conference Paper

References (40)

1. Barrett A. J., Davies M. E., and Grubb A. O. (1984) The place of human γ trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun. 120, 631-636.
2. Beyer K., Lao J. I., Gomez M., Riutort N., Latorre P., Mate J. L., and Ariza A. (2001) Alzheimer's disease and the cystatin C gene polymorphism: an association study. Neurosci. Lett. 315, 17-20.
3. Bobek L. A. and Levine M. J. (1992) Cystatins-inhibitors of cysteine proteinases. Crit. Rev. Oral Biol. Med. 3, 307-332.
4. Calero M., Pawlik M., Soto C., Castaño E. M., Sigurdsson E., Kumar A., et al. (2001) Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J. Neurochem. 77, 628-637.
5. Cohen D. H., Feiner H., Jensson O., and Frangione B. (1983) Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastrenteropancreatic neuroendocrine protein, γ trace. J. Exp. Med. 158, 623-628.
6. Crawford F. C., Freeman M. J., Schinka J. A., Abdullah L. I., Gold M., Hartman R., et al. (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 55, 763-768.
7. Dodel R. C., Du Y., Depboylu C., Kurz A., Eastwood B., Farlow M., et al. (2002) A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. Neurology 58, 664.
8. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., et al. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122-1124.
9. Esnard A., Esnard F., and Gauthier F. (1988) Purification of the cystatin C-like inhibitors from urine of nephropathic rats. Biol. Chem. Hoppe-Seyler. 369 (Suppl.), 219-222.
10. Esnard F., Esnard A., Faucher D., Capony J. P., Derancourt J., Brillard M., and Gauthier F. (1990) Rat cystatin C: the complete amino acid sequence reveals a site for N-glycosylation. Biol. Chem. Hoppe-Seyler. 371 (Suppl.), 161-166.
11. Finckh U., von Der Kammer H., Velden J., Michel T., Andresen B., Deng A., et al. (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch. Neurol. 57, 1579-1583.
12. Ghiso J., Jensson O., and Frangione B. (1986) Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis is a variant of γ trace basic protein (cystatin C). Proc. Natl. Acad. Sci. USA 83, 2974-2978.
13. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
14. Gudmundsson G., Hallgrimsson J., Jonasson T. A., and Bjarnason O. (1972) Hereditary cerebral haemorrhage with amyloidosis. Brain 95, 387-404.
15. Haan J., Maat-Schieman M. L. C., van Duinen S. G., Jensson O., Thorsteinsson L., and Roos R. A. C. (1994) Co-localization of β/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurol. Scand. 89, 367-371.
16. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., et al. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
17. Hochwald G. M., Pepe A. J., and Thorbecke G. J. (1967) Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of γ trace and β trace proteins. Proc. Soc. Exp. Med. 124, 961-966.
18. Huh C. G., Hakansson K., Nathanson C. M., Thorgeirsson U. P., Jonsson N., Grubb A., et al. (1999) Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. 52, 332-340.
19. Itoh Y., Yamada M., Hayakawa M., Otomo E., and Miyatake T. (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J. Neurol. Sci. 116, 135-141.
20. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
21. Levy E., Lopez-Otin C., Ghiso J., Geltner D., and Frangione B. (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J. Exp. Med. 169, 1771-1778.
22. Levy E., Sastre M., Kumar A., Gallo G., Piccardo M. D., Ghetti B., and Tagliavini F. (2001) Codeposition of cystatin C with amyloid-β protein in the brain of Alzheimer's disease patients. J. Neuropathol. Exp. Neurol. 60, 94-104.
23. Maruyama K., Ikeda S., Ishihara T., Allsop D., and Yanagisawa N. (1990) Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to β protein and cystatin C. Stroke 21, 397-403.
24. Maruyama H., Izumi Y., Oda M., Torii T., Morino H., Toji H., et al. (2001) Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease. Neurology 57, 337-339.
25. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
26. Olafsson I., Thorsteinsson L., and Jensson O. (1996) The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Brain Pathol. 6, 121-126.
27. Olson J. M., Goddard K. A., and Dudek D. M. (2002) A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am. J. Hum. Genet. 71, 154-161.
28. Palm D. E., Knuckey N. W., Primiano M. J., Spangenberger A. G., and Johanson C. E. (1995) Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res. 691, 1-8.
29. Roks G., Cruts M., Slooter A. J., Dermaut B., Hofman A., Van Broeckhoven C., and Van Duijn C. M. (2001) The cystatin C polymorphism is not associated with early onset Alzheimer's disease. Neurology 57, 366-367.
30. Rozmahel R., Huang J., Chen F., Liang Y., Nguyen V., Ikeda M., et al. (2002) Normal brain development in PS1 hypomorphic mice with markedly reduced γ-secretase cleavage of βAPP. Neurobiol. Aging 23, 187-194.
31. Sastre M., Calero M., Pawlik M., Mathews P. M., Kumar A., Danilov V, et al. (2004) Binding of cystatin C to Alzheimer's amyloid β inhibits amyloid fibril formation. Neurobiol. Aging, in press.
32. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., et al. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
33. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., et al. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
34. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
35. Steinhoff T., Moritz E., Wollmer M. A., Mohajeri M. H., Kins S., and Nitsch R. M. (2001) Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Neurobiol. Dis. 8, 647-654.
36. Taupin P., Ray J., Fischer W. H., Suhr S. T., Hakansson K., Grubb A., and Gage F. H. (2000) FGF-2-Responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28, 385-397.
37. Turk V. and Bode W. (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
38. Vattemi G., Engel W. K., McFerrin J., and Askanas V. (2003) Cystatin C colocalizes with amyloid-β and coimmunoprecipitates with amyloid β precursor protein in sporadic inclusion-body myositis muscles. J. Neurochem. 85, 1539-1546.
39. Vinters H. V., Nishimura G. S., Secor D. L., and Pardridge W. M. (1990) Immunoreactive A4 and γ trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am. J. Pathol. 137, 233-240.
40. Wei L., Walker L. C., and Levy E. (1996) Cystatin C: Icelandic-like mutation in an animal model of cerebrovascular β amyloidosis. Stroke 27, 2080-2085.